🧴image loading
(from DailyMed)

CVS Maximum OTC Strength Hemorrhoidal with Aloe GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM 144 mg/g; 2.5 mg/g; 10 mg/g; 150 mg/g Cream, 28 g — NDC 51316-203-01 (Billing 51316-0203-01)

by CVS PHARMACY,INC · 28 g in 1 TUBE

This is a package of 28 g of CVS Maximum OTC Strength Hemorrhoidal with Aloe GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM 144 mg/g; 2.5 mg/g; 10 mg/g; 150 mg/g Cream from CVS PHARMACY,INC, marketed since Nov 2025 and currently FDA-listed. It is this product's only package size.

NDC 51316-0203-01
🏷️ FDA NDC (as labeled) 51316-203-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 51316-203-01
Product NDC 51316-203
11-digit billing NDC 51316020301
RxCUI 1293649
UNII PDC6A3C0OX, 04JA59TNSJ, 88AYB867L5, B6E5W8RQJ4
Application # M015
SPL Set ID b55c63fb-5dfa-4567-8192-58f403868837
Established class (EPC) Non-Standardized Chemical Allergen
Physiologic effect Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production
Chemical class Allergens; Glycerol
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-11-25
Route TOPICAL
Dosage form CREAM
Substance GLYCERIN; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE; WHITE PETROLATUM
Quick answers
  • RxCUI (RxNorm): 1293649
Why two NDCs? The FDA registers this code as 51316-203-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 51316-0203-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Local anesthetics class.

Drug family (ATC) Local anesthetics, Anesthetics for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

This is an over-the-counter topical cream formulated for external use and marketed under FDA's OTC monograph rules for hemorrhoidal products. The active ingredients include phenylephrine hydrochloride, a decongestant that helps reduce swelling, and pramoxine hydrochloride, a numbing agent typically used to relieve itching and discomfort. Glycerin and white petrolatum function as moisturizing and protective base ingredients common in topical hemorrhoidal preparations.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
51316-0203-01 You're viewing this Main listing 28 g in 1 TUBE 2025-11-25 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Good Sense Hemorrhoidal Maximum Strength Pain Relief 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 00113-0944-24 L. 1 tube $0.046 — Availability likely —
Hemorrhoidal Cream .28 g/28g; 4.032 g/28g; .07 g/28g; 4.2 g/28g 70000-0425-01 Cardinal 1 tube $0.084 — Availability likely —
GNP Hemorrhoidal Maximum Strength 150 mg/g; 144 mg/g; 10 mg/g; 25 mg/g 46122-0776-37 Amerisourcebergen 1 tube $0.131 — Availability likely —
Hemorrhoidal Cream 150 mg/g; 144 mg/g; 10 mg/g; 2.5 mg/g 00363-0641-09 Walgreens 1 tube — — FDA listed —
Hemorrhoidal Pain Relief Cream 144 mg/g; 2.5 mg/g; 10 mg/g; 150 mg/g 00363-9127-01 WALGREENS 1 tube — — FDA listed —
PREPARATION H Maximum Strength 144 mg/g; 2.5 mg/g; 10 mg/g; 150 mg/g 00573-2868-10 Haleon 1 tube — — FDA listed —
Hemorrhoidal 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 11822-2944-00 Rite 1 tube — — Discontinued —
Hemorrhoidal Pain Relief 10 mg/g; 2.5 mg/g; 144 mg/g; 150 mg/g 13709-0335-01 Neilmed 1 tube — — FDA listed —
Signature Care Hemorrhoidal Cream (with applicator) 2.5 mg/g; 10 mg/g; 144 mg/g; 150 mg/g 21130-0981-02 BETTER 1 tube — — FDA listed —
hemorrhoidal maximum strength pain relief 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 30142-0944-24 Kroger 1 tube — — FDA listed —
topcare hemorrhoidal 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 36800-0944-24 Topco 1 tube — — FDA listed —
Equaline Hemorrhoidal 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 41163-0944-24 United 1 tube — — FDA listed —
hemorrhoidal 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 41250-0944-24 Meijer 1 tube — — FDA listed —
Hemorrhoidal 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 42507-0944-24 HyVee 1 tube — — FDA listed —
equate hemorrhoidal 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 49035-0944-24 Wal-Mart 1 tube — — FDA listed —
Nikzon Hemorrhoidal 144 mg/g; 150 mg/g; 2.5 mg/g; 10 mg/g 50066-0010-09 Genomma 1 tube — — FDA listed —
CVS Maximum OTC Strength Hemorrhoidal with Aloe 144 mg/g; 2.5 mg/g; 10 mg/g; 150 mg/gthis 51316-0203-01 CVS 28 g — — FDA listed —
Family Wellness HEMORRHOID 144 mg/g; 2.5 mg/g; 10 mg/g; 150 mg/g 55319-0981-25 FAMILY 1 tube — — FDA listed —
Family Wellness 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 55621-0012-01 Zhejiang 1 tube — — FDA listed —
hemorrhoidal 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 56062-0944-24 Publix 1 tube — — FDA listed —
Hemorrhoidal 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 59779-0944-24 CVS 1 tube — — FDA listed —
Hemorrhoidal Cream 1 g/100g; 15 g/100g; 14.4 g/100g; .25 g/100g 69396-0033-18 Trifecta 1 tube — — FDA listed —
Hemorrhoidal Cream 1 g/100g; 15 g/100g; 14.4 g/100g; .25 g/100g 69396-0171-18 Trifecta 1 tube — — FDA listed —
Family Wellness 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 69571-0004-02 FRONT 1 tube — — FDA listed —
CVS Health Hemorrhoidal Cream 14.4 g/100g; .25 g/100g; 1 g/100g; 15 g/100g 69571-0010-28 FRONT 1 tube — — FDA listed —
Thera Plus Hemorrhoidal 144 mg/g; 150 mg/g; 2.5 mg/g; 10 mg/g 80684-0141-00 FOURSTAR 26 g — — FDA listed —
Thera Plus Hemorrhoidal 144 mg/g; 2.5 mg/g; 10 mg/g; 150 mg/g 80684-0210-01 Fourstar 26 g — — FDA listed —
Up and Up Hemorrhoid MAX STRENGTH 144 mg/g; 2.5 mg/g; 10 mg/g; 150 mg/g 82442-0025-51 Target 1 tube — — FDA listed —
Hemorrhoidal Cream with Aloe 15 g/100g; .25 g/100g; 1 g/100g; 14.4 g/100g 83324-0044-09 Chain 1 tube — — FDA listed —
Maximum Strength Hemorrhoidal Cream with Aloe 15 g/100g; .25 g/100g; 1 g/100g; 14.4 g/100g 83324-0330-01 Chain 1 tube — — FDA listed —
Bloop Hemorrhoid Relief Topical 14.4 g/100g; 1 g/100g; 15 g/100g; .25 g/100g 83838-0155-01 Three 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Nov 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerCVS PHARMACY,INC
FDA applicationM015 (OTC MONOGRAPH DRUG)
Labeler code51316
First marketedNov 2025
Product typeHuman Otc Drug
Portfolio3 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 46 words ▾

Use for temporary relief of pain, soreness and burning helps relieve the local itching and discomfort associated with hemorrhoids temporarily provides a coating for relief of anorectal discomforts temporarily protects the inflamed irritated anorectal surface to help make bowel movements less painful temporarily shrinks hemorrhoidal tissue

⏱️ Dosage and Administration 65 words ▾

Directions Adults: when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product. apply externally to the affected area up to 4 times daily, especially at night or in the morning or after each bowel movement. Children under 12 years: ask a doctor.

⚠️ Warnings 158 words ▾

Warnings For external use only. When using this product do not put this product into the rectum by using fingers or any mechanical device do not exceed recommended daily dosage unless directed by a doctor Ask a doctor before use if you have heart disease high blood pressure thyroid disease diabetes trouble urinating due to an enlarged prostate gland Ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression Stop use and ask a doctor if bleeding occurs condition worsens or does not improve within 7 days if the symptoms being treated do not subside or if redness, irritation, swelling, pain or other symptoms develop or increase. some people can develop allergic reactions to ingredients in this product.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 19 words ▾

Active ingredients Glycerin 14.4% Phenylephrine HCl 0.25% Pramoxine HCl 1% White petrolatum 15% Purpose Protectant Vasoconstrictor Local anesthetic Protectant

🧪 Inactive Ingredients 24 words ▾

Inactive ingredients aloe barbadensis leaf extract, carboxymethylcellulose sodium, cetyl alcohol, glyceryl monostearate, methylparaben, paraffin, propylene glycol, propylparaben, stearic acid, tween 80, water, xanthan gum

🎯 Purpose 6 words ▾

Purpose Protectant Vasoconstrictor Local anesthetic Protectant

📄 Ask a Doctor Before Use If 24 words ▾

Ask a doctor before use if you have heart disease high blood pressure thyroid disease diabetes trouble urinating due to an enlarged prostate gland

📄 Ask a Doctor or Pharmacist Before Use If 21 words ▾

Ask a doctor or pharmacist before use if you are presently taking a prescription drug for high blood pressure or depression

📄 When Using This Product 30 words ▾

When using this product do not put this product into the rectum by using fingers or any mechanical device do not exceed recommended daily dosage unless directed by a doctor

📄 Stop Use and Ask a Doctor If 49 words ▾

Stop use and ask a doctor if bleeding occurs condition worsens or does not improve within 7 days if the symptoms being treated do not subside or if redness, irritation, swelling, pain or other symptoms develop or increase. some people can develop allergic reactions to ingredients in this product.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 8 words ▾

Other information store at room temperature 68°-77°F (20°-25°C)

📄 Questions or Comments 9 words ▾

Questions? 1-800-639-3803 Weekdays 9 AM to 4 PM EST

📄 Package Label / Principal Display Panel 3 words ▾

Package Labeling: Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM — the ingredient across all brands.

Top reported reactions

Anaemia1
Anorectal Discomfort1
Burning Sensation1
Chills1
Depression1
Diarrhoea1
Dyschezia1

Reporter sex

0 reports
Male · 67%
Female · 33%
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by CVS PHARMACY,INC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
CVS PHARMACY,INC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.